Novel approaches and perspectives in allergen immunotherapy
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
In this review, we report on relevant current topics in allergen immunotherapy (AIT) which were broadly discussed during the first Aarhus Immunotherapy Symposium (Aarhus, Denmark) in December 2015 by leading clinicians, scientists and industry representatives in the field. The aim of this symposium was to highlight AIT‐related aspects of public health, clinical efficacy evaluation, mechanisms, development of new biomarkers and an overview of novel therapeutic approaches. Allergy is a public health issue of high socioeconomic relevance, and development of evidence‐based action plans to address allergy as a public health issue ought to be on national and regional agendas. The underlying mechanisms are in the focus of current research that lays the ground for innovative therapies. Standardization and harmonization of clinical endpoints in AIT trials as well as current knowledge about potential biomarkers have substantiated proof of effectiveness of this disease‐modifying therapeutic option. Novel treatments such as peptide immunotherapy, intralymphatic immunotherapy and use of recombinant allergens herald a new age in which AIT may address treatment of allergy as a public health issue by reaching a large fraction of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randomized trial of peanut consumption in infants at risk for peanut allergy
Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414850 · Cited by 2,237
Environmental biodiversity, human microbiota, and allergy are interrelated
Hanski, I., von Hertzen, L., Fyhrquist, N., Koskinen, K., Torppa, K., Laatikainen, T., Karisola, P., Auvinen, P., Paulin, L., Mäkelä, M. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205624109 · Cited by 1,063
Prevalence and rate of diagnosis of allergic rhinitis in Europe
Bauchau, V., & Durham, S. R. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00013904 · Cited by 1,022
Self-citationJacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Koivikko, A., Norberg, L. A., Valovirta, E., Wahn, U., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01451.x · Cited by 976
Self-citationEAACI Molecular Allergology User's Guide
Matricardi, P. M., Kleine‐Tebbe, J., Hoffmann, H. J., Valenta, R., Hilger, C., Hofmaier, S., Aalberse, R. C., Agache, I., Asero, R., Ballmer‐Weber, B., et al. (2016) · Pediatric Allergy and Immunology · doi:10.1111/pai.12563 · Cited by 932
Self-citationArbes Jr., S. J., Gergen, P. J., Elliott, L., & Zeldin, D. C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.017 · Cited by 639
Staden, U., Rolinck‐Werninghaus, C., Brewe, F., Wahn, U., Niggemann, B., & Beyer, K. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01501.x · Cited by 466 · cited 1×
“Adverse side-effects during conventional OIT can be severe, and only half of the enrolled patients reach maintenance dose (23, 68).”
BackgroundSenti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803725105 · Cited by 364
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Senti, G., Crameri, R., Kuster, D., Johansen, P., Martinez-Gomez, J. M., Graf, N., Steiner, M., Hothorn, L. A., Grönlund, H., Tivig, C., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.026 · Cited by 271
Lao-Araya, M., Steveling, E., Scadding, G. W., Durham, S. R., & Shamji, M. H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.029 · Cited by 200 · cited 2×
“Recent studies have shown suppression of basophil activation (47, 48) and a decrease in circulating ILC2s (49).”
BackgroundSelf-citationPatel, D., Couroux, P., Hickey, P., Salapatek, A. M., Laidler, P., Larché, M., & Hafner, R. P. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.028 · Cited by 198
Self-citationHorak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Devillier, P., Montagut, A., Mélac, M., Galvain, S., Jean-Alphonse, S., Van Overtvelt, L., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.006 · Cited by 175
Self-citationNolte, H., Maloney, J., Nelson, H. S., Bernstein, D. I., Lu, S., Li, Z., Kaur, A., Zieglmayer, P., Zieglmayer, R., Lemell, P., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1911 · Cited by 160
Suárez-Fueyo, A., Ramos, T., Galán, A., Jimeno, L., Wurtzen, P. A., Marin, A., de Frutos, C., Blanco, C., Carrera, A. C., Barber, D., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.043 · Cited by 147 · cited 1×
“Peripheral CD25FOXP3, presumed T reg cells, increased after SLIT (61), findings confirmed in relation to grass SLIT (62).”
BackgroundZieglmayer, P., Focke-Tejkl, M., Schmutz, R., Lemell, P., Zieglmayer, R., Weber, M., Kiss, R., Blatt, K., Valent, P., Stolz, F., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.022 · Cited by 138
Klunker, S., Saggar, L. R., Seyfert-Margolis, V., Asare, A. L., Casale, T. B., Durham, S. R., & Francis, J. N. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.05.034 · Cited by 129
Self-citationIs intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Witten, M., Malling, H.-J., Blom, L., Poulsen, B. C., & Poulsen, L. K. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.033 · Cited by 100
Hylander, T., Larsson, O., Petersson-Westin, U., Eriksson, M., Kumlien Georén, S., Winqvist, O., & Cardell, L.-O. (2016) · Respiratory Research · doi:10.1186/s12931-016-0324-9 · Cited by 92 · cited 1×
“In a more recent double-blind placebocontrolled study with 36 patients, ILIT against birch and grass allergy significantly improved self-reported treatment outcomes (108), whereas there were no differences between the ILIT and placebo group in response to nasal allergen provocation and no differences in specific IgE o…”
BackgroundSelf-citationPatterson, A. M., Bonny, A. E., Shiels, W. E., & Erwin, E. A. (2016) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.11.010 · Cited by 74 · cited 1×
“In the first double-blind placebo-controlled trial of adolescents and the first on the American continent, treatment was safe but did not achieve statistical significance (109).”
BackgroundCD‐sens: a biological measure of immunological changes stimulated by ASIT
Nopp, A., Cardell, L. O., Johansson, S. G. O., & Öman, H. (2009) · Allergy · doi:10.1111/j.1398-9995.2008.01900.x · Cited by 67
Self-citationRösner-Friese, K., Kaul, S., Vieths, S., & Pfaar, O. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.045 · Cited by 66 · cited 2×
“A clear unmet need in the future is a thorough technical standardization and (clinical) validation within and between different AEC models (31, 34).”
BackgroundMethodSelf-citationEarly improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy
Schmid, J. M., Würtzen, P. A., Dahl, R., & Hoffmann, H. J. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.029 · Cited by 63 · cited 3×
“Recent studies have shown suppression of basophil activation (47, 48) and a decrease in circulating ILC2s (49).”
BackgroundSelf-citationZidarn, M., Košnik, M., Šilar, M., Bajrović, N., & Korošec, P. (2015) · Allergy · doi:10.1111/all.12581 · Cited by 46
Cited by
Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
Shamji, M. H., & Durham, S. R. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.010 · Cited by 446
Self-citationHaahtela, T. (2019) · Allergy · doi:10.1111/all.13763 · Cited by 407
Pathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
The role of allergen‐specific IgE, IgG and IgA in allergic disease
Shamji, M. H., Valenta, R., Jardetzky, T., Verhasselt, V., Durham, S. R., Würtzen, P. A., & van Neerven, R. J. J. (2021) · Allergy · doi:10.1111/all.14908 · Cited by 336
Self-citationAkdis (2020) · doi:10.1111/pai.13189 · Cited by 320
Metadata
- Authors
- Hoffmann, H. J., Valovirta, E., Pfaar, O., Moingeon, P., Schmid, J. M., Skaarup, S. H., Cardell, L. ‐., Simonsen, K., Larché, M., Durham, S. R., & Sørensen, P.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2017-03-20
- Volume
- 72
- Issue
- 7
- Pages
- 1022-1034
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2581300200
- Cited by
- 96
- References
- 23
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.